9/13/2026
Potential FDA approval of psychedelics impacts Japan
FDA approval of psychedelics like ibogaine could influence Japanese pharmacy practices.
Topic archive
regulatory context
3 stories
8/29/2026
Ibogaine clinic marks decade in kratom addiction care
David Dardashti's clinic highlights ten years of treating kratom addiction with ibogaine.
7/24/2026
White House debates psychedelic health policy
Internal discussions focus on potential therapeutic uses and regulatory challenges.